SII Investments’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-36,303
Closed -$3.87M 137
2017
Q4
$3.87M Sell
36,303
-5,706
-14% -$610K 0.4% 55
2017
Q3
$4.67M Sell
42,009
-798
-2% -$85.3K 0.27% 78
2017
Q2
$4.44M Sell
42,807
-966
-2% -$95.1K 0.27% 77
2017
Q1
$4.27M Sell
43,773
-2,694
-6% -$258K 0.29% 76
2016
Q4
$4.14M Buy
46,467
+141
+0.3% +$12.8K 0.31% 73
2016
Q3
$4.46M Sell
46,326
-5,307
-10% -$505K 0.34% 70
2016
Q2
$4.45M Sell
51,633
-9,069
-15% -$814K 0.36% 67
2016
Q1
$5.27M Buy
60,702
+4,650
+8% +$416K 0.5% 48
2015
Q4
$6.34M Sell
56,052
-3,708
-6% -$402K 0.8% 26
2015
Q3
$5.99M Buy
59,760
+54,000
+938% +$6.48M 0.69% 31
2015
Q2
$713K Sell
5,760
-606
-10% -$72.5K 0.08% 227
2015
Q1
$726K Buy
6,366
+168
+3% +$18.5K 0.09% 210
2014
Q4
$625K Sell
6,198
-1,149
-16% -$112K 0.08% 222
2014
Q3
$664K Buy
7,347
+1,617
+28% +$142K 0.09% 216
2014
Q2
$494K Sell
5,730
-30,609
-84% -$2.41M 0.07% 260
2014
Q1
$2.89M Buy
36,339
+828
+2% +$69K 0.54% 52
2013
Q4
$2.69M Buy
35,511
+627
+2% +$44.5K 0.48% 56
2013
Q3
$2.42M Buy
34,884
+3,705
+12% +$243K 0.57% 47
2013
Q2
$1.79M Buy
+31,179
New +$1.8M 0.39% 68

Other funds holding IBB

SII Investments's IBB Position: Q1 2018 in Review

SII Investments sold out of iShares Biotechnology ETF (IBB) in Q1 2018, closing a stake of 36,303 shares — an estimated $3.87M sold.

SII Investments first reported a position in IBB in Q2 2013 and held it in 19 quarters. The position peaked at $6.34M in Q4 2015. 608 funds tracked by Wall St. Rank hold IBB as of Q1 2018.

  • SII Investments reported no remaining iShares Biotechnology ETF position as of Q1 2018 after selling out during the quarter.
  • SII Investments sold 36,303 iShares Biotechnology ETF shares in Q1 2018, an estimated $3.87M.
  • SII Investments first reported a position in iShares Biotechnology ETF in Q2 2013 and held it in 19 quarters.
  • SII Investments's iShares Biotechnology ETF position peaked at $6.34M in Q4 2015.
  • 608 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2018.

Based on SII Investments's 13F filing for Q1 2018.